IDH1-mutated relapsed or refractory AML: current challenges and future prospects
Juan Eduardo Megías-Vericat,1 Octavio Ballesta-López,1 Eva Barragán,2,3 Pau Montesinos2,31Servicio de Farmacia, Área del Medicamento, Hospital Universitari i Politècnic La Fe, Valencia, Spain; 2Servicio de Hematología y Hemoterapia, Hospital Universitari i P...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2019-06-01
|
| Cyfres: | Blood and Lymphatic Cancer: Targets and Therapy |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.dovepress.com/idh1-mutated-relapsed-or-refractory-aml-current-challenges-and-future--peer-reviewed-article-BLCTT |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|